These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 12964066)

  • 21. Molecular crosstalk of probiotic bacteria with the intestinal immune system: clinical relevance in the context of inflammatory bowel disease.
    Hörmannsperger G; Haller D
    Int J Med Microbiol; 2010 Jan; 300(1):63-73. PubMed ID: 19828372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease?
    Seksik P; Dray X; Sokol H; Marteau P
    Mol Nutr Food Res; 2008 Aug; 52(8):906-12. PubMed ID: 18384087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease.
    Seksik P; Sokol H; Lepage P; Vasquez N; Manichanh C; Mangin I; Pochart P; Doré J; Marteau P
    Aliment Pharmacol Ther; 2006 Oct; 24 Suppl 3():11-8. PubMed ID: 16961738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding why probiotic therapies can be effective in treating IBD.
    Fedorak RN
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S111-5. PubMed ID: 18806699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probiotics as modulators of the gut flora.
    Fooks LJ; Gibson GR
    Br J Nutr; 2002 Sep; 88 Suppl 1():S39-49. PubMed ID: 12215180
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Host-bacterial interactions in inflammatory bowel disease.
    Mahida YR; Rolfe VE
    Clin Sci (Lond); 2004 Oct; 107(4):331-41. PubMed ID: 15212627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Do probiotics have a role in the management of inflammatory bowel disease?
    Morris JD; Diamond KA; Balart LA
    J La State Med Soc; 2009; 161(3):155-9. PubMed ID: 19772038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The long-term health effects of neonatal microbial flora.
    Conroy ME; Shi HN; Walker WA
    Curr Opin Allergy Clin Immunol; 2009 Jun; 9(3):197-201. PubMed ID: 19398905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rationale for probiotic treatment strategies in inflammatory bowel disease.
    Schultz M; Lindström AL
    Expert Rev Gastroenterol Hepatol; 2008 Jun; 2(3):337-55. PubMed ID: 19072384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Probiotics: from myth to reality. Demonstration of functionality in animal models of disease and in human clinical trials.
    Dunne C; Murphy L; Flynn S; O'Mahony L; O'Halloran S; Feeney M; Morrissey D; Thornton G; Fitzgerald G; Daly C; Kiely B; Quigley EM; O'Sullivan GC; Shanahan F; Collins JK
    Antonie Van Leeuwenhoek; 1999; 76(1-4):279-92. PubMed ID: 10532384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases.
    Tlaskalová-Hogenová H; Stepánková R; Hudcovic T; Tucková L; Cukrowska B; Lodinová-Zádníková R; Kozáková H; Rossmann P; Bártová J; Sokol D; Funda DP; Borovská D; Reháková Z; Sinkora J; Hofman J; Drastich P; Kokesová A
    Immunol Lett; 2004 May; 93(2-3):97-108. PubMed ID: 15158604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical usefulness of probiotics in inflammatory bowel diseases.
    Mach T
    J Physiol Pharmacol; 2006 Nov; 57 Suppl 9():23-33. PubMed ID: 17242485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Indications and challenges of probiotics, prebiotics, and synbiotics in the management of arthralgias and spondyloarthropathies in inflammatory bowel disease.
    Karimi O; Peña AS
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S136-41. PubMed ID: 18806706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probiotics and inflammatory bowel disease: from fads and fantasy to facts and future.
    Shanahan F
    Br J Nutr; 2002 Sep; 88 Suppl 1():S5-9. PubMed ID: 12215176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of antibiotics, prebiotics and probiotics in treatment for hepatic encephalopathy.
    Bongaerts G; Severijnen R; Timmerman H
    Med Hypotheses; 2005; 64(1):64-8. PubMed ID: 15533613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolving knowledge and therapy of inflammatory bowel disease.
    Korzenik JR; Podolsky DK
    Nat Rev Drug Discov; 2006 Mar; 5(3):197-209. PubMed ID: 16518373
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Review article: antibiotics and probiotics in inflammatory bowel disease.
    Kruis W
    Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():75-8. PubMed ID: 15352898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Natural therapy instead of chemistry? Probiotics in gastroenterology].
    Kirchgatterer A; Knoflach P
    Acta Med Austriaca; 2004 Feb; 31(1):13-7. PubMed ID: 15259592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Probiotics: history, definition, requirements and possible therapeutic applications].
    Montalto M; Arancio F; Izzi D; Cuoco L; Curigliano V; Manna R; Gasbarrini G
    Ann Ital Med Int; 2002; 17(3):157-65. PubMed ID: 12402663
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bacteria in the pathogenesis of inflammatory bowel disease.
    Subramanian S; Campbell BJ; Rhodes JM
    Curr Opin Infect Dis; 2006 Oct; 19(5):475-84. PubMed ID: 16940872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.